{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:47:05Z","timestamp":1767772025198,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2505800"],"award-info":[{"award-number":["2022YFC2505800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971308"],"award-info":[{"award-number":["81971308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10388-023-01012-0","type":"journal-article","created":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T07:01:22Z","timestamp":1683442882000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Caution against simultaneous integrated boost radiotherapy for upper thoracic esophageal squamous cell carcinoma: results from a single-arm phase II trial"],"prefix":"10.1007","volume":"20","author":[{"given":"Yue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiquan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yida","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,7]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1012_CR2","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94\u201305) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167\u201374.","journal-title":"J Clin Oncol"},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13014-021-01749-x","volume":"16","author":"J Ristau","year":"2021","unstructured":"Ristau J, Thiel M, Katayama S, et al. Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity. Radiat Oncol. 2021;16:23.","journal-title":"Radiat Oncol"},{"key":"1012_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00066-014-0636-y","volume":"190","author":"W-W Yu","year":"2014","unstructured":"Yu W-W, Zhu Z-F, Fu X-L, et al. Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study. Strahlenther Onkol. 2014;190:979\u201386.","journal-title":"Strahlenther Onkol"},{"key":"1012_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/bjs.5081","volume":"92","author":"H Igaki","year":"2005","unstructured":"Igaki H, Kato H, Tachimori Y, et al. Surgery for clinical T3 carcinomas of the upper thoracic oesophagus and the need for new strategies. Br J Surg. 2005;92:1235\u201340.","journal-title":"Br J Surg"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jtcvs.2012.07.002","volume":"144","author":"B Li","year":"2012","unstructured":"Li B, Chen H, Xiang J, et al. Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg. 2012;144:778\u201386.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1245\/s10434-013-2987-5","volume":"20","author":"Z Zhu","year":"2013","unstructured":"Zhu Z, Yu W, Li H, et al. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2013;20:3052\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1012_CR8","doi-asserted-by":"crossref","unstructured":"Esophagus. In: Greene FL, Page DL, Fleming ID et al. editors. AJCC Cancer Staging Manual. New York, NY: Springer New York; 2002. p. 91\u20138.","DOI":"10.1007\/978-1-4757-3656-4_9"},{"key":"1012_CR9","doi-asserted-by":"crossref","unstructured":"Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14(1):1\u201336.","DOI":"10.1007\/s10388-016-0551-7"},{"key":"1012_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10388-016-0556-2","volume":"14","author":"Japanese Classification of Esophageal Cancer","year":"2017","unstructured":"Japanese Classification of Esophageal Cancer. Japanese classification of esophageal cancer, 11th edition: part II and III. Esophagus. 2017;14:37\u201365.","journal-title":"Esophagus"},{"key":"1012_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2214\/ajr.136.6.1051","volume":"136","author":"AA Moss","year":"1981","unstructured":"Moss AA, Schnyder P, Thoeni RF, et al. Esophageal carcinoma: pretherapy staging by computed tomography. AJR Am J Roentgenol. 1981;136:1051\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"1012_CR12","first-page":"139","volume":"36","author":"GU Yajia","year":"2002","unstructured":"Yajia GU, Wang J, Xiang J. A study on clinical value of CT features of tracheoesophageal groove lymph node metastasis of thoracic esophageal carcinoma. Chin J Radiol. 2002;36:139\u201341.","journal-title":"Chin J Radiol"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"S2671","DOI":"10.21037\/jtd.2018.03.182","volume":"10","author":"XB D'Journo","year":"2018","unstructured":"D\u2019Journo XB. Clinical implication of the innovations of the 8 edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis. 2018;10:S2671\u201381.","journal-title":"J Thorac Dis"},{"key":"1012_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.radonc.2014.11.022","volume":"113","author":"M Liu","year":"2014","unstructured":"Liu M, Chen Y, Fu X, et al. Proposed revision of CT-based cervical and thoracic lymph node levels for esophageal cancer in UICC 7th version. Radiother Oncol. 2014;113:175\u201381.","journal-title":"Radiother Oncol"},{"key":"1012_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","volume":"29","author":"JH Maduro","year":"2003","unstructured":"Maduro JH, Pras E, Willemse PHB, et al. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29:471\u201388.","journal-title":"Cancer Treat Rev"},{"key":"1012_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13014-019-1249-5","volume":"14","author":"C Li","year":"2019","unstructured":"Li C, Ni W, Wang X, et al. A phase I\/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal cancer. Radiat Oncol. 2019;14:48.","journal-title":"Radiat Oncol"},{"key":"1012_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.radonc.2007.03.013","volume":"83","author":"S Kumar","year":"2007","unstructured":"Kumar S, Dimri K, Khurana R, et al. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiother Oncol. 2007;83:139\u201347.","journal-title":"Radiother Oncol"},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jamaoncol.2019.2809","volume":"5","author":"D Chen","year":"2019","unstructured":"Chen D, Menon H, Verma V, et al. Results of a phase 1\/2 trial of chemoradiotherapy with simultaneous integrated boost of radiotherapy dose in unresectable locally advanced esophageal cancer. JAMA Oncol. 2019;5:1597\u2013604.","journal-title":"JAMA Oncol"},{"key":"1012_CR19","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1200\/JCO.20.03697","volume":"39","author":"MCCM Hulshof","year":"2021","unstructured":"Hulshof MCCM, Geijsen ED, Rozema T, et al. Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study). J Clin Oncol. 2021;39:2816\u201324.","journal-title":"J Clin Oncol"},{"key":"1012_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/path.5389","volume":"250","author":"WH McBride","year":"2020","unstructured":"McBride WH, Schaue D. Radiation-induced tissue damage and response. J Pathol. 2020;250:647\u201355.","journal-title":"J Pathol"},{"key":"1012_CR21","doi-asserted-by":"publisher","first-page":"doaa128","DOI":"10.1093\/dote\/doaa128","volume":"34","author":"T Wedel","year":"2021","unstructured":"Wedel T, Heinze T, M\u00f6ller T, et al. Surgical anatomy of the upper esophagus related to robot-assisted cervical esophagectomy. Dis Esophagus. 2021;34:doaa128.","journal-title":"Dis Esophagus"},{"key":"1012_CR22","first-page":"421","volume":"29","author":"RK Mittal","year":"2013","unstructured":"Mittal RK. Longitudinal muscle of the esophagus: its role in esophageal health and disease. Curr Opin Gastroenterol. 2013;29:421\u201330.","journal-title":"Curr Opin Gastroenterol"},{"key":"1012_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1097\/JTO.0000000000000267","volume":"9","author":"L He","year":"2014","unstructured":"He L, Allen PK, Potter A, et al. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Oncol. 2014;9:1398\u2013405.","journal-title":"J Thorac Oncol"},{"key":"1012_CR24","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ijrobp.2009.05.070","volume":"76","author":"M Werner-Wasik","year":"2010","unstructured":"Werner-Wasik M, Yorke E, Deasy J, et al. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys. 2010;76:S86\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1012_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000503754","volume":"43","author":"C Zhu","year":"2020","unstructured":"Zhu C, Wang S, You Y, et al. Risk factors for esophageal fistula in esophageal cancer patients treated with radiotherapy: a systematic review and meta-analysis. Oncol Res Treat. 2020;43:34\u201341.","journal-title":"Oncol Res Treat"},{"key":"1012_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3748\/wjg.v24.i7.862","volume":"24","author":"JW Kim","year":"2018","unstructured":"Kim JW, Kim TH, Kim J-H, et al. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy. World J Gastroenterol. 2018;24:862\u20139.","journal-title":"World J Gastroenterol"},{"key":"1012_CR27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hed.25483","volume":"41","author":"TH Kim","year":"2019","unstructured":"Kim TH, Lee IJ, Kim J-H, et al. High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study. Head Neck. 2019;41:146\u201353.","journal-title":"Head Neck"},{"key":"1012_CR28","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/OTT.S130285","volume":"10","author":"X Wang","year":"2017","unstructured":"Wang X, Miao C, Chen Z, et al. Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis. Onco Targets Ther. 2017;10:2087\u201395.","journal-title":"Onco Targets Ther"},{"key":"1012_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2008.09.025","volume":"92","author":"M Onozawa","year":"2009","unstructured":"Onozawa M, Nihei K, Ishikura S, et al. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol. 2009;92:266\u20139.","journal-title":"Radiother Oncol"},{"key":"1012_CR30","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/cas.13308","volume":"108","author":"Z Jing","year":"2017","unstructured":"Jing Z, Chen T, Zhang X, et al. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer. Cancer Sci. 2017;108:1828\u201333.","journal-title":"Cancer Sci"},{"key":"1012_CR31","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1200\/JCO.2008.16.6918","volume":"26","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter K, Komaki R, et al. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol. 2008;26:4551\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-023-01012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10388-023-01012-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-023-01012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T07:48:53Z","timestamp":1702367333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10388-023-01012-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s10388-023-01012-0","relation":{},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"type":"print","value":"1612-9059"},{"type":"electronic","value":"1612-9067"}],"subject":[],"published":{"date-parts":[[2023,5,7]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Administration Committee of Fudan University Shanghai Cancer Center, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}